Abstract
Oculopharyngeal muscular dystrophy (OPMD) presents with ptosis and dysphagia in the fifth or sixth decade of life. The transmission is autosomal dominant and the course is slowly progressive; patients can go on to develop limb weakness later in the illness. Histology shows rimmed vacuoles and tubulofilamentous inclusions in the nuclei. Treatment is largely supportive.
References
Abu-Baker A, Rouleau GA. Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies. Biochim Biophys Acta. 2007;1772:173–85.
Blumen SC, Nisipeanu P, Sadeh M, Asherov A, Blumen N, Wirguin Y, et al. Epidemiology and inheritance of oculopharyngeal muscular dystrophy in Israel. Neuromuscul Disord. 1997;71:S38–40.
Bouchard JP, Brais B, Brunet D, Gould PV, Rouleau GA. Recent studies on oculopharyngeal muscular dystrophy in Quebec. Neuromuscul Disord. 1997;7(Suppl 1):S22–9.
Brais B. Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease, Cytogenet. Genome Res. 2003;100:252–60.
Brais B, Xie YG, Sanson M, Morgan K, Weissenbach J, Korczyn AD, Blumen SC, Fardeau M, Tome FM, Bouchard JP, Rouleau GA. The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac alpha and beta myosin heavy chain genes on chromosome 14q11.2–q13. Hum Mol Genet. 1995;4:429–34.
Brais B, Bouchard JP, Xie YG, Rochefort DL, Chrétien N, Tomé FM, Lafreniere RG, Rommens JM, Uyama E, Nohira O, Blumen S, Korczyn AD, Heutink P, Mathieu J, Duranceau A, Codere F, Fardeau M, Rouleau GA. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet. 1998;18:164–7.
Brais B, Rouleau GA, Bouchard JP, Fardeau M, Tomé FM. Oculopharyngeal muscular dystrophy. Semin Neurol. 1999;19:59–66.
Davies JE, Wang L, Garcia-Oroz L, Cook LJ, Vacher C, O'donovan DG, Rubinsztein DC. Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice. Nat Med. 2005;6:672–7.
Duranceau A. Cricophryngeal myotomy in the management of neurogenic and muscular dysphagia. Neuromuscul Disord. 1997;7(suppl 1):S85–9.
Isenberg DA, Kahn P. Familial late onset oculopharyngeal muscular dystrophy. Postgrad Med J. 1981;57:41–3.
Little WB, Perl DP. Oculopharyngeal muscular dystrophy. An autopsied case from the French-Canadian Kindred. J Neurol Sci. 1982;53:145–58.
Maksimova NR, Nikolaeva IA, Korotkov MN, Ikeuchi T, Onodera O, Nishizava M, et al. The clinical-genealogic and molecular-genetic characteristics of oculopharyngeal muscular dystrophy in the Republic of Sakha (Yakutia). Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108:52–60.
Mathieu J, Lapointe G, Brassard A, et al. A pilot study on upper esophageal sphincter dilation for the treatment of dysphagia in patients with oculopharyngeal muscular dystrophy. Neuromuscul Disord. 1997;7(suppl 1):S100–4.
Rodrigue D, Molgat YM. Surgical correction of blepharoptosis in oculopharyngeal muscular dystrophy. Neuromuscul Disord. 1997;7(suppl 1):S82–4.
Rüegg S, Lehky Hagen M, Hohl U, Kappos L, Fuhr P, Plasilov M, Hüller H, Heinimann K. Oculopharyngeal muscular dystrophy an underdiagnosed disorder? Swiss Med Wkly. 2005;135:574–86.
Sarkar AK, Biswas SK, Ghosh AK, Mitra P, Ghosh SK, Mathew J. Oculopharyngeal muscular dystrophy. Indian J Pediatr. 1995;62:496–8.
Taylor WM. Progressive vagus-glossopharyngeal paralysis with ptosis. Contribution to group of family diseases. J Nerv Ment Dis. 1915;42:129–39.
Tomé F, Fardeau M. In: Engel AG, Franzini-Armstrong C, editors. Oculopharyngeal muscular dystrophy, myology, vol. 2. New York: McGraw-Hill; 1994. p. 1233–45.
Tomé FM, Chateau D, Helbling-Leclerc A, Fardeau M. Morphological changes in muscle fibers in oculopharyngeal muscular dystrophy. Neuromuscul Disord. 1997a;7:S63–9.
Tomé FMS, Chateau D, Helbling-Leclerc A, Fardeau M. Morphological changes in muscle fibers in oculopharyngeal muscular dystrophy. Neuromuscul Disord. 1997b;7(Suppl 1):S63–9.
Victor M, Hayes R, Adams RD. Oculopharyngeal muscular dystrophy. A familial disease of late life characterized by dysphagia and progressive ptosis of the eyelids. N Engl J Med. 1962;267:1267–72.
Xu WZ. Relation between HLA and oculopharyngeal muscular dystrophy–study of a large family. Zhonghua Shen Jing Jing Shen Ke Za Zhi. 1985;18:326–9.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Khadilkar, S.V., Yadav, R.S., Patel, B.A. (2018). Oculopharyngeal Muscular Dystrophy. In: Neuromuscular Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-10-5361-0_17
Download citation
DOI: https://doi.org/10.1007/978-981-10-5361-0_17
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-5360-3
Online ISBN: 978-981-10-5361-0
eBook Packages: MedicineMedicine (R0)